Trademark Overview
On Monday, August 30, 2021, a trademark application was filed for PROGRAMMABLE CELL THERAPY with the United States Patent and Trademark Office. The USPTO has given the PROGRAMMABLE CELL THERAPY trademark a serial number of 97002928. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 25, 2022. This trademark is owned by Arsenal Biosciences, Inc.. The PROGRAMMABLE CELL THERAPY trademark is filed in the Pharmaceutical Products category with the following description:
Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
